Clinical Trials Logo

Filter by:
NCT ID: NCT02875067 Terminated - Clinical trials for Relapsed Non-Hodgkin Lymphoma

Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma

Start date: August 29, 2016
Phase: Phase 1/Phase 2
Study type: Interventional

This trial is to assess the safety & efficacy of the Combination of Pembrolizumab and Lenalidomide in the management of patients with Relapsed Hodgkin Lymphoma.

NCT ID: NCT02873650 Terminated - Hepatic Impairment Clinical Trials

Pharmacokinetics of Dabrafenib in Subjects With Hepatic Impairment

Start date: December 20, 2016
Phase: Phase 1
Study type: Interventional

To characterize the pharmacokinetics and safety of dabrafenib following a single 100 mg oral dose in subjects with moderate and severe hepatic impairment.

NCT ID: NCT02872935 Terminated - Nausea Clinical Trials

Minimizing Nausea and Vomiting During Spinals for CS

Start date: May 15, 2015
Phase: Phase 4
Study type: Interventional

In parturients undergoing Cesarean section under spinal anesthesia, co-loading of 1 liter of crystalloids, with placing the spinal, along with administering a phenylephrine infusion and glycopyrrolate, enables placing a spinal with minimal perioperative nausea and vomiting and good intra and post-operative pain relief.

NCT ID: NCT02872831 Terminated - Pancreatic Cancer Clinical Trials

Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle

Start date: July 2016
Phase: N/A
Study type: Interventional

The primary objective of this proposed prospective randomized, multi-center study is to evaluate the capability of the new 22G SharkCore™ needle to obtain tissue specimens and to compare its performance against the standard 22G BNX Endoscopic Ultrasound Fine needle aspiration (Beacon Endoscopic, Newton, MA) needle in the evaluation of solid mass lesions in the pancreas and gastrointestinal tract. The secondary objective is to determine the ability of the 22G SharkCore™ needle system to yield histologic tissue.

NCT ID: NCT02872428 Terminated - Trauma Clinical Trials

A Study to Evaluate the Safety and Tolerability of Valproic Acid in Trauma Patients(Part 2)

Start date: November 2016
Phase: Phase 1
Study type: Interventional

THIS IS THE SECOND PART OF A 2-PART STUDY. The purpose of the first part of this study was to determine the safety and tolerability of ascending doses of valproic acid (also known as Depacon) administered as intravenous infusion (IV) in doses ranging from 15 mg/kg to 250 mg/kg in healthy subjects. ID: VPA-C-002 The second part of the study will also be to determine the safety and tolerability of single ascending doses of valproic acid administered as IV in trauma subjects with hemorrhagic shock.

NCT ID: NCT02871427 Terminated - Clinical trials for Dementia With Lewy Bodies

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Start date: October 20, 2016
Phase: Phase 2
Study type: Interventional

This study seeks to evaluate the long-term safety and effectiveness of nelotanserin for the treatment of visual hallucinations (VHs) and Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD) in subjects with Lewy body dementia (LBD).

NCT ID: NCT02871297 Terminated - Clinical trials for Depressive Disorder, Major

Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age

Start date: August 17, 2016
Phase: Phase 3
Study type: Interventional

Evaluation of the long-term safety and tolerability of vortioxetine in child and adolescent participants with a Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5™) diagnosis of MDD.

NCT ID: NCT02871102 Terminated - Clinical trials for Acute Respiratory Distress Syndrome

Stress Index to Individualize Mechanical Ventilation in ARDS

Start date: August 2016
Phase: N/A
Study type: Interventional

Acute respiratory distress syndrome (ARDS) is a widely prevalent and morbid disease for which the current standard treatment is supportive care and avoidance of complications with lung-protective ventilation. Lower-tidal volume ventilation has been largely accepted as a means of lung protective ventilation, but the mechanism for its effectiveness is not yet clear, and debate remains as to how best to choose positive end-expiratory pressure (PEEP). Reduction in driving pressure (plateau pressure minus PEEP) has been suggested as a possible means to minimize ventilator-induced lung injury. This protocol aims to identify the range of safe paired-settings of PEEP and tidal volume, with selection guided by driving pressure and the stress index, a tool to recognize potential lung hyperinflation during mechanical ventilation.

NCT ID: NCT02868892 Terminated - Clinical trials for Adenocarcinoma of the Cervix

A Study of Pemetrexed in Recurrent Cervical Adenocarcinomas

Start date: July 2015
Phase: Phase 2
Study type: Interventional

Patients with advanced or recurrent adenocarcinoma or adenosquamous cell carcinoma of the cervix will receive Pemetrexed.

NCT ID: NCT02867904 Terminated - Clinical trials for Arthroscopic Shoulder Surgery

Intra-Operative Corticosteroid Injection During Arthroscopic Shoulder Surgery

Start date: March 2016
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the efficacy of intra-operative subacromial corticosteroid injections in patients undergoing arthroscopic shoulder surgery on quality of life scores and activity level when compared to a control group.